Nomura Holdings
FRTX

Nomura Holdings’s Fresh Tracks Therapeutics, Inc. Common Stock FRTX Stock Holding History

Nomura Holdings’s Portfolio FRTX Stock Details FRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-11
Closed -$44K – 2395
2013
Q3 		$44K Buy
+11
New +$82.5K ﹤0.01% 2135

Other funds holding FRTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LM
Litespeed Management New York $48.2M AUM 9.81% 1-Year Est. Return
TC
TFS Capital West Chester, Pennsylvania $255M AUM 32.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Nomura Holdings's FRTX Position: Q4 2013 in Review

Nomura Holdings sold out of Fresh Tracks Therapeutics, Inc. Common Stock (FRTX) in Q4 2013, closing a stake of 11 shares — an estimated $44K sold.

Nomura Holdings first reported a position in FRTX in Q3 2013 and held it in 1 quarter. The position peaked at $44K in Q3 2013. 79 funds tracked by Wall St. Rank hold FRTX as of Q4 2013.

  • Nomura Holdings reported no remaining Fresh Tracks Therapeutics, Inc. Common Stock position as of Q4 2013 after selling out during the quarter.
  • Nomura Holdings sold 11 Fresh Tracks Therapeutics, Inc. Common Stock shares in Q4 2013, an estimated $44K.
  • Nomura Holdings first reported a position in Fresh Tracks Therapeutics, Inc. Common Stock in Q3 2013 and held it in 1 quarter.
  • Nomura Holdings's Fresh Tracks Therapeutics, Inc. Common Stock position peaked at $44K in Q3 2013.
  • 79 funds tracked by Wall St. Rank held Fresh Tracks Therapeutics, Inc. Common Stock as of Q4 2013.

Based on Nomura Holdings's 13F filing for Q4 2013, filed 14 Feb 2014.